Tuesday, February 25, 2020

Aurobindo Pharma gets EIR with VAI status from USFDA for Hyderabad facility

Aurobindo Pharma gets EIR with VAI status from USFDA for Hyderabad facility According to the US health regulator, a VAI classification "means objectionable conditions or practices were found but the agency is not prepared to take or recommend any administrative or regulatory action".

from Moneycontrol Business News https://ift.tt/32sdjPt
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

FIIs ease bearish bets post-Budget, but charts warn of range-bound Nifty: Anand James

Foreign investors are reducing their negative bets on the market after the Budget. However, the market's overall sentiment remains delic...